• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Imago Biosciences Inc (NQ: IMGO )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Jan 10, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Imago Biosciences Inc

    < Previous 1 2 3 Next >
    7 Healthcare Stocks That Will Be Big Winners in 2023
    Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider. 
    Via InvestorPlace
    5 Top Pharma Stocks of 2022 to Buy for the Long Haul
    The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
    Via InvestorPlace
    Looking Into Imago BioSciences's Recent Short Interest
    Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular... 
    Via Benzinga
    5 Most Expensive Health Care Stocks You Should Worry About
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
    From Merck & Co., Inc.
    Via Business Wire
    Analyst Ratings for Imago BioSciences
    Via Benzinga
    What 5 Analyst Ratings Have To Say About Imago BioSciences
    Via Benzinga
    Expert Ratings for Imago BioSciences
    Via Benzinga
    How Is The Market Feeling About Imago BioSciences?
    Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 13.61% of all regular... 
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    3 Dow Stocks to Take Seriously in 2023
    The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
    Via Benzinga
    IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Imago BioSciences, Inc. - IMGO
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday
    Via Benzinga
    TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune
    Via AB Newswire
    Topics Death Economy Stocks
    Exposures COVID-19 Death Interest Rates
    Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
    Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash. 
    Via Benzinga
    Nasdaq Down More Than 100 Points; Gold Falls 1%
    U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday. 
    Via Benzinga
    Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
    Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      During Monday's session, 50 stocks hit new 52-week highs. 
    Via Benzinga
    OPEC Rumors, Energy Stocks Drag Wall Street
    The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well. 
    Via Talk Markets
    Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher
    U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday. 
    Via Benzinga
    Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
    U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion
    Imago BioSciences, Inc. (NASDAQ: IMGO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development 
    Via Spotlight Growth
    As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
    Markets sent mixed messages to start out Thanksgiving week. 
    Via The Motley Fool
    Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
    Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. 
    Via InvestorPlace
    Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney
    U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday. 
    Via Benzinga
    Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout
    Seagen who? Merck is putting its cash to work buying a smaller biotech company. 
    Via Investor's Business Daily
    IMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.